CLINICAL_TRIALS
trial_result
· 2011-12-20
Clinical Trial Update: Safety and Tolerability of AFFITOPE AD03 [Phase 1]
Summary
Phase 1 trial assessing the safety and tolerability of AFFITOPE AD03 in Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Affiris AG | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED